Literature DB >> 12237064

Postal survey on the use of glycerol-preserved allografts in clinical practice.

David Mackie1.   

Abstract

Glycerol-preserved allografts (GPAs) are in widespread use throughout Europe in the management of burns injury. However, little is known of the clinical usage and effectiveness of GPA. To gain more insight into clinical practice, The Euro Skin Bank (ESB), which is the main provider of GPA, sent a questionnaire to 62 burn centres which had received GPA from the ESB in the last 5 years. Replies from 37 centres were received, of which 31 contained useful information. Ninety percent of correspondents used GPA regularly, although 24% of centres would prefer to use cryo-preserved allografts and 16% preferred fresh allografts. Three principal indications for GPA were identified: its use as a temporary cover on freshly excised wounds; its use as an overlay on widely expanded autografts and its use to improve the quality of the wound bed prior to autografting. Twenty-five percent of correspondents used GPA as a biological dressing for partial thickness injuries.Pre-operative topical therapy consisted of semi-closed wound treatment with frequent dressing changes and application of silver sulfadiazine (SSD) or SSD with 1% cerium nitrate. Twenty percent of correspondents also used povidone iodine.The surgical approach of early excision and wound coverage (autograft or allograft) were followed by all correspondents. Graft fixation was achieved by staples alone or in combination with fibrin glue or adhesive dressings. Post-operative care comprised frequent dressing changes. Few clinicians used topical antibacterial agents and peri-operative antibiotics were prescribed by a third of correspondents. Few complications were reported following GPA use. Around 50% of clinicians reported "occasional" wound infection; around 50% of clinicians reported "occasional" graft failure. In general, GPA appeared to perform well in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12237064     DOI: 10.1016/s0305-4179(02)00092-x

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  7 in total

Review 1.  State of the art in burn treatment.

Authors:  Bishara S Atiyeh; S William Gunn; Shady N Hayek
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

2.  Evolving practice of the Helsinki Skin Bank.

Authors:  Andrew J Lindford; Ira Frey; Jyrki Vuola; Virve Koljonen
Journal:  Int Wound J       Date:  2010-05-18       Impact factor: 3.315

Review 3.  [Skin graft procedures in burn surgery].

Authors:  H-O Rennekampff
Journal:  Unfallchirurg       Date:  2009-06       Impact factor: 1.000

4.  Deceased donor skin allograft banking: Response and utilization.

Authors:  Madhuri A Gore; Anuradha S De
Journal:  Indian J Plast Surg       Date:  2010-09

5.  Glycerol treatment as recovery procedure for cryopreserved human skin allografts positive for bacteria and fungi.

Authors:  Gilbert Verbeken; Gunther Verween; Daniel De Vos; Bruno Pascual; Peter De Corte; Cornelia Richters; Arlette De Coninck; Diane Roseeuw; Nadine Ectors; Thomas Rose; Serge Jennes; Jean-Paul Pirnay
Journal:  Cell Tissue Bank       Date:  2011-03-01       Impact factor: 1.522

6.  Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies.

Authors:  John S Graham; Robert P Chilcott; Paul Rice; Stephen M Milner; Charles G Hurst; Beverly I Maliner
Journal:  J Burns Wounds       Date:  2005-01-05

7.  Glycerolized Reticular Dermis as a New Human Acellular Dermal Matrix: An Exploratory Study.

Authors:  Pietro Maria Ferrando; Davide Balmativola; Irene Cambieri; Maria Stella Scalzo; Massimiliano Bergallo; Laura Annaratone; Stefania Casarin; Mara Fumagalli; Maurizio Stella; Anna Sapino; Carlotta Castagnoli
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.